Beijing Tiantan Biological Products Co., Ltd. (SHSE: 600161)
Health Care · Biotechnology · CN
CN¥12.73
+1.11% today · -34.2% 1Y
Beijing Tiantan Biological Products Co., Ltd. (SHSE: 600161) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.76B and employs 5,205 people.
Over the last twelve months the share price has lost 34.2%, trading between 11.12 and 19.38.
Tweenvest scores Beijing Tiantan Biological Products Co., Ltd. across four factors: quality 81/100, value 51/100, growth 62/100, dividend 16/100. Its strongest factor is quality.
600161 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.76B
- Revenue (TTM)
- $832.21M
- P/E
- 33.48
- EPS
- 0.38
- Dividend yield
- 1.57%
- Beta (5Y)
- 0.22
- 52-week high
- CN¥19.38
- 52-week low
- CN¥11.12
- Avg volume (3M)
- —
- Shares outstanding
- 1.98B
- Employees
- 5,205
- Next earnings
- —
About Beijing Tiantan Biological Products Co., Ltd.
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
- ISIN
- CNE000000WF9
- Founded
- 1966
- Listed since
- Jun 16, 1998
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $4.12B | CN¥104.25 | -5.23% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $4.01B | $24.00 | +0.80% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $3.92B | $17.62 | -1.45% |
| Telix Pharmaceuticals LimitedASX: TLX | $3.76B | AU$15.85 | -0.13% |
| Hualan Biological Engineering Inc.SZSE: 002007 | $3.64B | CN¥13.35 | +0.07% |
| Veracyte, Inc.NasdaqGM: VCYT | $3.64B | $45.25 | +0.04% |
| Legend Biotech CorporationNasdaqGS: LEGN | $3.61B | $18.75 | +0.70% |
| Xenon Pharmaceuticals Inc.NasdaqGM: XENE | $3.53B | $36.35 | -0.25% |
Figures last refreshed Oct 11, 2026.